Reply to thread

Message: [QUOTE="BLUEDOGHOUSE, post: 3982399, member: 981"] I have T1D. When the 365 day implantable sensor is approved (end of 2023) with the transmitter also subcutaneous it should really disrupt the market even with Dexcom most likely having rolled out by then the Dex G8 and G9. I wear the G7. The 180 is tempting but the 365 will be a MA$$IVE game changer. You need to be somewhat patient with this one. Submission of data from the SBA sensors is where this study packs a real powerful punch. They are really providing data IMO on what to expect for efficiency with the 365 day. Some may miss that part of the study. [/QUOTE]